Nephros Inc. (NEPH) vs Retractable Technologies, Inc. (RVP)

Nephros Inc. and Retractable Technologies, Inc. are both Medical Instruments & Supplies companies. Nephros Inc. is the larger, with a market value of $45.0M against $20.5M — 2.2× the size. Retractable Technologies, Inc. has negative trailing earnings, so its P/E is not meaningful; Nephros Inc. trades at 27.2×. Nephros Inc. grew revenue faster over the last twelve months: 24.2% against −11.2%. Nephros Inc. has the higher net margin (8.38% vs −10.6%) and the higher return on invested capital (14.1% vs −42.1%). Across the 19 metrics below, Nephros Inc. leads on 14 and Retractable Technologies, Inc. on 5.

Valuation

Metric NEPH RVP Medical Instruments & Supplies median
P/E 27.15 n/m 34.17
P/S 2.22 0.62 2.83
P/B 3.84 0.29 2.82
Price to free cash flow n/m n/m 25.69
EV/EBITDA 23.83 1.22 16.08
EV/Sales 2.03 (0.54) 3.06
Earnings yield 3.68% (17.14%) (1.84%)
Free cash flow yield (1.71%) (24.37%) 0.17%

Profitability

Metric NEPH RVP Medical Instruments & Supplies median
Gross margin 61.26% (1.45%) 54.62%
Operating margin 7.92% (66.90%) 1.64%
Net margin 8.38% (10.62%) 0.00%
Free cash flow margin (3.19%) (15.07%) 1.61%
Return on equity 16.10% (4.84%) 0.00%
Return on assets 12.39% (2.49%) 0.00%
Return on invested capital 14.11% (42.05%) 0.00%

Growth

Metric NEPH RVP Medical Instruments & Supplies median
Revenue growth (TTM) 24.20% (11.16%) 9.20%
EPS growth (last fiscal year) 1,471.43% (7.50%) —
Revenue growth, 5-year CAGR 17.02% (14.11%) 9.48%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NEPH RVP Medical Instruments & Supplies median
Debt to equity 0.00 0.01 0.08
Current ratio 4.07 4.93 2.49
Net debt to EBITDA (4.20) 2.69 0.83

Dividend

Metric NEPH RVP Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio 0.00 0.00 0.00

Size

Metric NEPH RVP Medical Instruments & Supplies median
Market cap 44.96m 20.45m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack